Matrix Metalloproteinase-9 (MMP9)—A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders
Open Access
- 31 August 2009
- journal article
- research article
- Published by Hindawi Limited in Cardiovascular Psychiatry and Neurology
- Vol. 2009, 1-7
Abstract
Matrix metalloproteinase-9 (MMP9) has been implicated in numerous somatic illnesses, including cardiovascular disorders and cancer. Recently, MMP9 has been shown to be increasingly important in several aspects of central nervous system activity. Furthermore, a pathogenic role for this enzyme has been suggested in such neuropsychiatric disorders as schizophrenia, bipolar illness, and multiple sclerosis. In this paper, the results of biochemical and molecular-genetic studies on MMP9 that have been performed in these pathological conditions will be summarized. Furthermore, I hypothesize that the MMP9 gene, as shown by functional −1562 C/T polymorphism studies, may be mediating the relationship of neuropsychiatric illnesses (schizophrenia, bipolar mood disorder, multiple sclerosis) that are comorbid with cardiovascular disease and cancer.Keywords
This publication has 66 references indexed in Scilit:
- Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the CommunityCirculation, 2009
- Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009
- Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosisMultiple Sclerosis Journal, 2009
- Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal PopulationPLOS ONE, 2008
- Important role of matrix metalloproteinase 9 in epileptogenesisJournal of Cell Biology, 2008
- Physical illness and schizophrenia: a review of the literatureActa Psychiatrica Scandinavica, 2007
- Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery diseaseAmerican Heart Journal, 2007
- Elevated urinary ADAM12 protein levels in lithium-treated bipolar patientsJournal of Neural Transmission, 2006
- Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancerBreast Cancer Research and Treatment, 2005
- MORTALITY IN NORWEGIAN MENTAL HOSPITALS FROM 1916 TO 1933Acta Psychiatrica Scandinavica, 1936